Ignite Creation Date:
2024-05-05 @ 5:24 PM
Last Modification Date:
2024-10-26 @ 9:31 AM
Study NCT ID:
NCT00448825
Status:
UNKNOWN
Last Update Posted:
2013-03-15
First Post:
2007-03-15
Brief Title:
Novel Pharmacotherapy for Dual Dependence
Sponsor:
Bankole Johnson
Organization:
University of Virginia
Study Overview
Official Title:
Novel Pharmacotherapy for Dual Dependence
Status:
UNKNOWN
Status Verified Date:
2013-03
Last Known Status:
RECRUITING
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The purpose of this study is to evaluate the effects of Topiramate and Cognitive Behavioral Therapy for the treatment of alcohol and cocaine dependence
Detailed Description:
Our objective is to understand the basic mechanisms that underpin substance dependence and to develop efficacious treatments for individuals with comorbid cocaine and alcohol dependence
Participants in this study will be randomly assigned to receive either 300 mg per day of topiramate or placebo In addition participants will receive weekly cognitive behavioral therapy for 12 weeksFollow-up visits will occur at 2 weeks and 12 and 3 months following completion of treatment
Participants in this study will be randomly assigned to receive either 300 mg per day of topiramate or placebo In addition participants will receive weekly cognitive behavioral therapy for 12 weeksFollow-up visits will occur at 2 weeks and 12 and 3 months following completion of treatment
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None
Secondary IDs
| Secondary ID | Type | Domain | Link |
|---|---|---|---|
| R01DA019804 | NIH | None | None |
| DPMCDA | OTHER | NIDA | httpsreporternihgovquickSearchR01DA019804 |